Lung transplantation is a well-accepted treatment for people with most end-stage lung diseases. Although both tacrolimus and cyclosporin are used as primary immunosuppressive agents in lung transplant recipients, it is unclear which of these drugs is better in reducing rejection and death without causing adverse effects.
Journal review article
Cochrane Database of Systematic Reviews, 2013, Vol 5, p. 1-47
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review